Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Guangli Xiao"'
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e35601- (2024)
Groundwater pollution resulting from leachate leakage at landfill sites has garnered significant attention. Investigating the migration of pollutants from these landfills to adjacent groundwater is crucial for understanding the diffusion patterns and
Externí odkaz:
https://doaj.org/article/2ef5ce510bb14d869eec54b572bb2e9b
Autor:
Tianying Lv, Xiaoxun Xu, Guochun Lv, Changlian Xu, Guiyin Wang, Shirong Zhang, Zhanbiao Yang, Zhang Cheng, Junzhuo Cai, Ting Li, Yulin Pu, Wenzhi Gan, Zhien Pu, Guangli Xiao
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 261, Iss , Pp 115108- (2023)
Wood vinegar (WV) is a renewable organic compound, possessing characteristics such as high oxygenated compound content and low negative impact on soil. Based on its weak acid properties and complexing ability to potentially toxic elements (PTEs), WV
Externí odkaz:
https://doaj.org/article/4e971347ce7f41b2a36ef22ab2f79c9a
Autor:
Victor Ho-Fun Lee, MD, Joseph Siu Kie Au, MD, Ju-Wei Mu, MD, Guangli Xiao, MD, Fiona Mei Ying Lim, FRCR, Hon Chi Suen, FACS, Kam Hung Wong, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100308- (2022)
Introduction: Decision-making in diagnosis and management of stage III NSCLC remains complex owing to disease heterogeneity and diverse treatment options, and often warrants multidisciplinary team discussion. Specifically, the selection of patients f
Externí odkaz:
https://doaj.org/article/2a6d72d3465c446b89965ac151322a18
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0221575 (2019)
Osimertinib showed encouraging efficacy in patients with advanced EGFR T790M-positive NSCLC in previous randomized controlled trials. This real-world study aimed to evaluate the effectiveness and safety of osimertinib in a real-world setting. This ob
Externí odkaz:
https://doaj.org/article/76433e8d9fc44259b8de6354fd9ddb06
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114008 (2014)
INTRODUCTION: We report the efficacy and safety of crizotinib treatment among Chinese patients with advanced-stage NSCLC. METHODS: We retrospectively analyzed patients with EML4-ALK positive advanced NSCLC who were treated with crizotinib from May 20
Externí odkaz:
https://doaj.org/article/b4606a40722d4222b2e95dcdbdca719b
Publikováno v:
Cognitive Computation. 15:323-336
Publikováno v:
Applied Intelligence.
Publikováno v:
Expert Systems with Applications. 215:119307
Publikováno v:
Journal of Ambient Intelligence and Humanized Computing.
Publikováno v:
Engineering Applications of Artificial Intelligence. 118:105703